Browsing by Subject "Health care organization"

Article

ESMO consensus conferences: Another source of ESMO clinical practice guidelines

Pavlidis, Nicholas; Stahel, R. A.; Pentheroudakis, George; Cervantes, A. (2012)

Article

ESMO minimum clinical recommendations - The beginning of a process

Stahel, R. A.; Purkalne, Gunta; Herrstedt, J.; Jelic, S.; Fervers, B.; Kloke, O.; Mellstedt, H.; Pavlidis, Nicholas; Jost, Lorenz M. (2001)

Article

ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)

Briassoulis, E. Ch; Ch, F. Tolis; Pavlidis, Nicholas (2001)

Article

Heterogeneity in cancer guidelines: Should we eradicate or tolerate?

Pentheroudakis, George; Stahel, R. A.; Hansen, H.; Pavlidis, Nicholas (2008)

Background: Heterogeneity in aspects of development, structure and context of oncology guidelines was not evaluated. We analysed and critically examined its implications. Materials and methods: Nine cancer clinical practice ...

Article

Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group

Fountzilas, George; Papakostas, P.; Dafni, U.; Makatsoris, T.; Karina, M.; Kalogera-Fountzila, Anna; Maniadakis, N.; Aravantinos, Gerasimos; Syrigos, K.; Bamias, A. T.; Christodoulou, C.; Economopoulos, T.; Kalofonos, H. P.; Nikolaou, A.; Angouridakis, N.; Stathopoulos, G. P.; Bafaloukos, Dimitrios; Pavlidis, Nicholas; Daniilidis, J. (2006)

Background: The prognosis of patients with recurrent and/or metastatic head and neck cancer (HNC) is poor. Median survival of these patients following chemotherapy is in the range of 6 to 9 months. In the present randomized ...